Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Proteome Sciences Announces £5M Placing

Published: Monday, February 24, 2014
Last Updated: Monday, February 24, 2014
Bookmark and Share
Company conditionally places 17,857,143 new ordinary shares.

Proteome Sciences plc announces that it has conditionally placed 17,857,143 new ordinary shares of 1p each to raise £5 million before expenses with new and existing investors at 28p per share to provide additional working capital for the Company. Christopher Pearce, Chief Executive of the Proteome Sciences, has subscribed for 3,571,429 New Ordinary Shares in the Placing at the Placing Price. Following this transaction Christopher Pearce will hold 35,109,504 ordinary shares in the Company representing 16.4 per cent. of the Company’s enlarged share capital.

Application will be made for the New Ordinary Shares to be admitted to trading on AIM and it is expected that dealings in the New Ordinary Shares will commence trading at 08:00 on or around 28 February 2014. Following Admission, The New Ordinary Shares will, when issued, rank pari passu in all respects with the existing ordinary shares. 

In conformity with rule 5.6.1 of Disclosure and Transparency Rules, the Board of the Company notifies the market of the following:

The total number of ordinary shares of 1p each in Proteome in issue following the admission of the 17,857,143 New Ordinary Shares will be 214,105,620 with each share carrying the right to one vote. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Proteome Sciences under the FCA's Disclosure and Transparency Rules.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Deep Protein Profiling Key
Company has encouraged by two recent reports that emphasise the importance of protein profiling to improve outcomes in cancer treatment.
Wednesday, April 06, 2016
Proteome Sciences Extends its Reach Through Collaboration with MedBiomix Partners
Collaborative network alliance provide advanced data-driven solutions to integrate and make better use of protein expression data.
Wednesday, February 04, 2015
Appointment of Non-Executive Director
Company Board announces the appointment of Mr. Martin Diggle.
Friday, October 17, 2014
Proteome Sciences Signs $2m Contract with Genting TauRx Diagnostic Centre
Contract to develop diagnostic panels to detect Alzheimer’s disease and monitor treatment efficacy.
Tuesday, September 30, 2014
Science and Technology Award for TMT at HUPO World Congress
TMT® chemical tags, distributed through Thermo Scientific, have become the global market leader.
Monday, September 15, 2014
Breakthrough Profiling Technology to Improve Cancer Treatment on a Personalized Basis
New research paper published in the peer reviewed journal PLOS ONE.
Saturday, April 12, 2014
Proteome Sciences Appoints Director of Personalised Medicine
Proteome Sciences announces it has appointed Dr Chee Gee See as Director of Personalised Medicine with immediate effect.
Wednesday, October 30, 2013
Proteome Sciences to Develop Cancer Pathway Profiling Assays
New MS3 TMT® mass spectrometry technique to determine relative quantitation of proteins in multiple samples simultaneously.
Monday, June 17, 2013
In-vivo Study Shows CK1D Inhibitors Improve Cognition in Alzheimer’s Model
Proteome Sciences study shows improved cognition using its compounds.
Thursday, January 03, 2013
Stroke Blood Test That Could Increase Use of Most Effective Treatment Five-Fold
UNIGE in collaboration with Proteome Sciences describe a simple blood test.
Friday, September 21, 2012
CK1D Development Update
Proteome Sciences has achieved further milestones in the development of inhibitors of the casein kinase 1 delta (CK1d) target in its Alzheimer's disease portfolio.
Tuesday, August 07, 2012
Stroke Biomarker License to Randox
Stroke biomarker to develop and produce diagnostic tests that could increase by fivefold the number of patients treated for stroke.
Friday, April 06, 2012
Completion of Alzheimer’s Plasma Biomarker Study
The preliminary results demonstrate significant diagnostic and prognostic utilities.
Wednesday, April 04, 2012
Scientific News
Scientists Find Evidence That Cancer Can Arise Changes
Researchers at Rockefeller University have found a mutation that affects the proteins that package DNA without changing the DNA itself can cause a rare form of cancer.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Triple-Negative Breast Cancer Target Is Found
Researchers at UC Berkeley discover a target that drives cancer metabolism in triple-negative breast cancer.
Crucial Reaction for Vision Revealed
Scientists have tracked the reaction of a protein responding to light, paving the way for a new understanding of life's essential reactions.
Cancer Can Arise from Histone Mutations
A mutation that affects the proteins that package DNA—without changing the DNA itself—can cause a rare form of cancer.
Mimicking Evolution to Create Novel Proteins
A study by researchers in the Kuhlman lab offers a new route to design the 'cellular machines' needed to understand and battle diseases.
Can Gender Play A Role In Determining Cancer Treatment Choices?
MD Anderson study reveals “sex-biased” gene signatures in review of 13 cancer types.
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
FNIH Launches Project to Evaluate Biomarkers in Cancer Patients
Company has announced that it has launched a new project to evaluate the effectiveness of liquid biopsies as biomarkers in colorectal cancer patients.
HIV Particles Used to Trap Intact Mammalian Protein Complexes
Belgian scientists from VIB and UGent developed Virotrap, a viral particle sorting approach for purifying protein complexes under native conditions.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!